International standards for IgG and IgM anti-β2glycoprotein antibody measurement

Lupus

Volumn 23, Issue 12, 2014, Pages 1317-1319

  Willis, R ^a   Grossi, C ^b   Orietta Borghi, M ^b,c   Martos Sevilla, G ^d   Zegers, I ^d   Sheldon, J ^e   Meroni, P L ^b,c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d JOINT RESEARCH CENTRE   (Italy)

^e ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Anti 2glycoprotein I antibodies; reference materials; standardization

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1;

ANTIBODY AFFINITY; ANTIPHOSPHOLIPID SYNDROME; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; MEASUREMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION; SPECTROPHOTOMETRY; STANDARD; BLOOD; IMMUNOLOGY; STANDARDS;

AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; REFERENCE STANDARDS;

EID: 84908673890     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314544535     Document Type: Conference Paper

References (10)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
2. Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: Understanding the antibodies. Nat Rev Rheumatol. 2011 ; 7: 330-339
3. Meroni PL, Biggioggero M, Pierangeli SS, Sheldon J, Zegers I, Borghi MO. Standardization of autoantibody testing: A paradigm for serology in rheumatic diseases. Nat Rev Rheumatol. 2014 ; 10: 35-43
4. Meroni PL, Chighizola CB, Rovelli F, Gerosa M. Antiphospholipid syndrome in 2014: More clinical manifestations, novel pathogenic players and 2 emerging biomarkers. Arth Res Ther 2014 [in press].
5. de Laat B, Derksen RH, Urbanus RT, de Groot PG. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood. 2005 ; 105: 1540-1545
6. Pengo V, Banzato A, Denas G, et al. Correct laboratory approach to APS diagnosis and monitoring. Autoimmun Rev. 2013 ; 12: 832-834
7. Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC. European Forum on Antiphospholipid Antibodies Standardization Group. Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays. Thromb Haemost. 2005 ; 94: 665-672
8. Pierangeli SS, Favaloro EJ, Lakos G, et al. Standards and reference materials for the anticardiolipin and anti-β(2)glycoprotein I assays: A report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta. 2012 ; 413: 358-360
9. Lakos G, Favaloro EJ, Harris EN, et al. International consensus guidelines on anticardiolipin and anti-β(2) glycoprotein I testing: A report from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies. Arthritis Rheum. 2012 ; 64: 1-10
10. Tincani A, Spatola L, Prati E, et al. The antibeta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. J Immunol. 1996 ; 157: 5732-5738